hCD19/hCD3E

Nomenclature

C57BL/6Smoc-Cd19tm1(hCD19)Cd3etm1(hCD3E)/Smoc

Cat. NO.

NM-HU-190027

Strain State

Embryo cryopreservation

Export PDF

Model Description

This CD19 and CD3E double knockin strain is established by crossing CD19-HU and CD3E-HU mice together. These double double knockin mouse models can be useful for evalueting the efficacy of potential immunotherapy drug combinations.
Research Application：Immune-related

Validation Data

image.png

Fig1. Detection of CD19 expression in spleen by RT-PCR. Wild type: only one band at 368 bp with primers F1/R1(mCd19);Homoygous: only one band at 334 bp with primers F2/R2(hCD19); Abbr.. M, DNA marker; HO, homozygous; HE, heterozygous; WT, wild type.

image.png

Fig2. Detection of CD3E expression in spleen by RT-PCR. Wild type: only one band at 465 bp with primers F1/R1(mCd3e);Homoygous: one band at 516 bp with primers F1/R1(recombinant hCD3E) and one band at 349 bp with primers F2/R2(hCD3E); Abbr.. M, DNA marker; HO, homozygous; HE, heterozygous; WT, wild type.

image.png

Fig3. Immunotype in blood in hCD19/hCD3E mice 

image.png

Fig4. Immunotype in blood in hCD19/hCD3E mice 

image.png

Fig5. Immunotype in spleen in hCD19/hCD3E mice 

image.png

Fig6. Immunotype in bone marrow in hCD19/hCD3E mice 

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more